News

CVS Health price target raised to $71 from $51 at Baird
Baird raised the firm’s price target on CVS Health (CVS) to $71 from $51 and keeps a Neutral rating on the shares. The firm sees minimal ...
CVS Health (CVS) Gets a Buy from Truist Financial
Truist Financial analyst David S Macdonald maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...